Lucy Shapiro, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 271,685 shares at $34.45 ($9.5M) on 2014-12-12, disclosed to the SEC on 2014-12-12.
Open-market sale of $9.5M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.79 | 687 | $25K | 0.3% |
| 2 | $35.79 | 834 | $30K | 0.3% |
| 3 | $35.79 | 1,500 | $54K | 0.6% |
| 4 | $35.79 | 3,000 | $107K | 1.1% |
| 5 | $35.79 | 7,500 | $268K | 2.8% |
| 6 | $35.79 | 12,500 |
| $447K |
| 4.7% |
| 7 | $35.79 | 15,000 | $537K | 5.6% |
| 8 | $35.79 | 30,000 | $1.1M | 11.3% |
| 9 | $34.91 | 30,801 | $1.1M | 11.3% |
| 10 | $34.92 | 120,032 | $4.2M | 44.0% |
| 11 | $34.45 | 44,384 | $1.5M | 16.1% |
| 12 | $34.48 | 5,447 | $188K | 2.0% |
| Total | $35.06 avg | 271,685 | $9.5M | 100% |
| Filing → |
| ANAC | SELL | 2013-04-19 | $200K | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |
| ANAC | SELL | 2012-10-05 | $200K | — | Filing → |